Fetal safety of erythromycin. An update of Swedish data.
(2014) In European Journal of Clinical Pharmacology 70(3). p.355-360- Abstract
- In previous studies from the Swedish Medical Birth Register, a possible association between erythromycin therapy and an increased risk for cardiovascular defects was found. Other studies using different methodology have not verified this observation. The finding resulted in a warning for the use of erythromycin in early pregnancy, followed by a marked decline in such use. The present study was conducted to follow up on the previous observations and to find methodological explanations for the variation in results in these different published studies.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/4223519
- author
- Källén, Bengt LU and Danielsson, Bengt R
- organization
- publishing date
- 2014
- type
- Contribution to journal
- publication status
- published
- subject
- in
- European Journal of Clinical Pharmacology
- volume
- 70
- issue
- 3
- pages
- 355 - 360
- publisher
- Springer
- external identifiers
-
- pmid:24352632
- wos:000330994200014
- scopus:84894435293
- pmid:24352632
- ISSN
- 1432-1041
- DOI
- 10.1007/s00228-013-1624-3
- language
- English
- LU publication?
- yes
- id
- 19100cf0-0045-45d4-bc0f-549a83283c88 (old id 4223519)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/24352632?dopt=Abstract
- date added to LUP
- 2016-04-01 11:07:32
- date last changed
- 2022-03-12 20:04:31
@article{19100cf0-0045-45d4-bc0f-549a83283c88,
abstract = {{In previous studies from the Swedish Medical Birth Register, a possible association between erythromycin therapy and an increased risk for cardiovascular defects was found. Other studies using different methodology have not verified this observation. The finding resulted in a warning for the use of erythromycin in early pregnancy, followed by a marked decline in such use. The present study was conducted to follow up on the previous observations and to find methodological explanations for the variation in results in these different published studies.}},
author = {{Källén, Bengt and Danielsson, Bengt R}},
issn = {{1432-1041}},
language = {{eng}},
number = {{3}},
pages = {{355--360}},
publisher = {{Springer}},
series = {{European Journal of Clinical Pharmacology}},
title = {{Fetal safety of erythromycin. An update of Swedish data.}},
url = {{http://dx.doi.org/10.1007/s00228-013-1624-3}},
doi = {{10.1007/s00228-013-1624-3}},
volume = {{70}},
year = {{2014}},
}